Biomedicines – Talk Bio

Generate:Biomedicines Launches Global Phase 3 Trials for AI-Engineered Anti-TSLP Antibody GB-0895 in Severe Asthma

1 week ago talkbio0Tagged AI-engineered antibody, Asthma, Biomedicines, Clinical Trials, GB-0895, Generate, Phase 3, Programmable Biology, Severe (severity modifier), SOLAIRIA-1, SOLAIRIA-2, thymic stromal lymphopoietin, TSLP gene

Generate:Biomedicines; GB-0895; Phase 3 clinical trials; TSLP; thymic stromal lymphopoietin; severe asthma; AI-engineered antibody; programmable biology; SOLAIRIA-1; SOLAIRIA-2

Flagship’s Most-Funded Startups, Generate and Tessera, Announce Layoffs in 2025

5 months ago talkbio0Tagged Biomedicines, Flagship, layoffs, Pioneering, startups, Tessera

Flagship Pioneering; startups; Generate:Biomedicines; Tessera; layoffs; biotech; 2025

Pfizer Expands Collaboration with Flagship Pioneering, Adding Ampersand Biomedicines and Montai Therapeutics

1 year ago talkbio0Tagged Ampersand, Biomedicines, Drug Development, Flagship, Montai, Non-Small Cell Lung Carcinoma, Obesity, Pfizer, Pioneering, strategic partnership

Pfizer, Flagship Pioneering, Ampersand Biomedicines, Montai Therapeutics, strategic partnership, drug development, obesity, non-small cell lung cancer